# EDGAR Filing Document

**Accession Number:** 0001835579
**File Stem:** 0001193125-25-201427
**Filing Date:** 2025-9
**Character Count:** 2388
**Document Hash:** e2fbd91ba3066e070bf243cc2f4df93d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-201427.hdr.sgml**: 20251120

**ACCESSION NUMBER**: 0001193125-25-201427

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250911

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ImageneBio, Inc.
- **CENTRAL INDEX KEY:** 0001835579
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 811697316
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 12526 HIGH BLUFF DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130
- **BUSINESS PHONE:** 857-343-8292

**MAIL ADDRESS:**
- **STREET 1:** 12526 HIGH BLUFF DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ikena Oncology, Inc.
- **DATE OF NAME CHANGE:** 20201208

**ImageneBio, Inc.** 

**12526 High Bluff Drive, Suite 345** 

**San Diego, CA 92130** 

**(858) 345-6265**

September 11, 2025

**VIA EDGAR**

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3010

Attn: Tyler Howes

---

| | |
|:---|:---|
| **Re:** | **ImageneBio, Inc.**  |

---

**Registration Statement on Form S-1**

**File No. 333-290108**

**Acceleration Request** 

**Requested Date: Monday, September 15, 2025** 

**Requested Time: 4:00 p.m. Eastern Time** 

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the "***Registrant***") hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1 (the "***Registration Statement***") to become effective at 4:00 p.m. Eastern Time on Monday, September 15, 2025, or as soon thereafter as is practicable.

Once the Registration Statement has been declared effective, please orally confirm that event with Patrick Loofbourrow of Cooley LLP at (858) 550-6090 or Asa Henin of Cooley LLP at (858) 550-6104.

Sincerely,

---

| | |
|:---|:---|
| **ImageneBio, Inc.** | **ImageneBio, Inc.** |
| By: | /s/ Jotin Marango |
|  | Jotin Marango, M.D., Ph.D. |
|  | Chief Financial Officer and Corporate Secretary |

---